Oppenheimer Analyst Note Highlights Competitive Pressure on ANI Pharmaceuticals' Eye-Care Franchise

Oppenheimer analysts have indicated that ANI Pharmaceuticals' eye-care franchise is facing increased competitive pressures, which may pose market challenges for this segment of the company's portfolio. This assessment underscores the current competitive landscape in the eye-care sector and its implications for ANI Pharmaceuticals' market position.